Gene: ASPHD2
Official Full Name: aspartate beta-hydroxylase domain containing 2provided by HGNC
Gene Summary: Predicted to enable dioxygenase activity and metal ion binding activity. Located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19627 | ASPHD2 Knockout cell line (HCT 116) | Human | ASPHD2 | 1:2~1:4 | Negative | Online Inquiry |
KO19628 | ASPHD2 Knockout cell line (HEK293) | Human | ASPHD2 | 1:3~1:6 | Negative | Online Inquiry |
KO19629 | ASPHD2 Knockout cell line (A549) | Human | ASPHD2 | 1:3~1:4 | Negative | Online Inquiry |
ASPHD2 Gene Knockout Cell Lines represent a significant advancement in the study of biological functions and disease mechanisms associated with the ASPHD2 gene, known to be implicated in various metabolic processes. These specially engineered cell lines have undergone targeted gene editing to disrupt the expression of the ASPHD2 gene, allowing researchers to investigate the specific roles of this gene in cellular pathways and its contribution to the broader physiological context.
The primary function of ASPHD2 Gene Knockout Cell Lines lies in their ability to facilitate the elucidation of gene function by providing a robust model that mimics the absence of the ASPHD2 protein. These knockout cell lines act as a powerful tool for studying downstream effects on metabolic regulation, cellular signaling pathways, and potential alterations in disease states. By comparing these knockout cells to their wild-type counterparts, researchers can delineate the specific molecular mechanisms by which ASPHD2 influences cellular behaviors, offering insights relevant to both basic research and therapeutic development.
The scientific importance of these cell lines extends to a range of applications, including drug discovery, functional genomics, and understanding metabolic disorders. They are invaluable in clinical research settings where elucidating the role of specific genes can pave the way for novel therapeutic interventions or biomarker identification for diseases linked to ASPHD2 dysfunction.
What sets the ASPHD2 Gene Knockout Cell Lines apart from conventional cell models is their high specificity and reliability, ensuring that researchers can achieve consistent and reproducible results. Compared to alternatives that may exhibit residual gene activity or variability, these knockout lines grant unparalleled clarity in data interpretation, ultimately leading to more accurate conclusions regarding the gene's function.
For researchers and clinicians alike, the ASPHD2 Gene Knockout Cell Lines represent a unique opportunity to enhance our understanding of gene function and their implications in health and disease. They support innovative research initiatives aimed at developing targeted therapies and elucidating the complex pathways of gene regulation.
As a leader in the field of biological products, our company is dedicated to providing meticulously developed cellular models that meet the highest standards of scientific excellence, empowering researchers to advance their work with confidence and clarity.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.